Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Example Input: Paragraph: The California deaths were caused by a strain of the influenza virus that is sending sufferers across the nation to the doctor for flu-like symptoms at rates that are 50 percent higher than normal, said Lyn Finelli, head of the influenza surveillance and outbreak response team at the Centers for Disease Control and Prevention. “That’s way above the norm for flu,” Finelli said. “It tells us we’re still in the middle of flu season, and in the Northeast and California it’s going up, up, up.”  The flu strain responsible for the California deaths, H1N1, also predominates nationwide this year. It hits people hardest between the ages of 25 and 64, partly because some older people are believed to have more immunity due to similar outbreaks many decades ago. In California, 52 people died last week alone, including one child, the state’s chief of communicable disease control told reporters on a conference call Friday. “This influenza season continues to be a severe one as the increasing number of influenza-related deaths indicates,” Ron Chapman, director of the California Department of Public Health, said in a statement, urging Californians to get vaccinated. In addition to the 147 confirmed California flu-related fatalities this season among people under age 65, another 44 suspected flu deaths remain under investigation, said Dr. James Watt, chief of the state’s Division of Communicable Disease Control. Most of those felled by the disease had other health conditions, but not all, he said. Last year at the same time, the state had recorded just 14 flu deaths among Californians under age 65. The death of a 47-year-old television advertising executive in the state’s capital city prompted a renewed call for residents to become vaccinated against flu. Sacramento County, with 21 deaths so far, leads the state in fatalities. “After reading the heartbreaking story of Nancy Pinnella, went to CVS and got my first flu shot ever,” California’s first lady, Anne Gust Brown, posted on Twitter. It is not fully clear whether California is an outlier in the severity of its cases, because states are not required to report flu deaths to the CDC, and data is collected differently from state to state and county to county, said CDC spokesman Jason McDonald. The fatality data that the public health agency does collect, on pediatric deaths, is not useful in studying H1N1, because the virus is more likely to attack adults, Finelli said. The public health agency does, however collect information on why people go to the doctor, and whether they are hospitalized for flu. Those signs, she said, show that this year’s flu is likely to continue to hit hard. Although the number of cases nationwide appears to have plateaued, she said, that does not take into account that California and the Northeast are lagging other areas with a late flu season. Meanwhile, CDC data does show that far more people under the age of 65 are being hospitalized with flu-like symptoms than last year. As of last week, for example, 76 percent of those hospitalized for flu were under age 65, compared to less than 50 percent last year. Nationwide, the data shows that somewhat fewer people have contracted flu so far this year than last year, Finelli said. This year’s strain, however, appears to be causing severe illness in a population that is more typically robust, she said. Claim: California sees high rate of flu deaths in unusually severe season.
Example Output: An unusually severe flu season has claimed the lives of at least 147 young and middle-aged people in California - 10 times the number killed by influenza viruses by the same time last year, public health officials said on Friday.

Example Input: Paragraph: Health Minister Olivier Veran told a briefing he could not determine at this stage when the lockdown would end. If the government were to follow the scientific council’s advice, France would remain at a virtual standstill until April 28. A statement by the council, which advises President Emmanuel Macron on the coronavirus crisis, also said the lockdown was the only really efficient strategy at the moment and “needs to be strictly implemented”. Prime Minister Edouard Philippe said on Monday the widespread lockdown in France could last several more weeks and his government was tightening restrictions on daily life even further. Veran also said France would heed World Health Organization recommendations to increase coronavirus testing. Health agency chief Jerome Salomon said later France would soon be able to conduct 10,000 tests a day. Salomon reported 240 new deaths from coronavirus on Tuesday for a total of 1,100, an increase of 28% that made France the fifth nation to cross the 1,000-fatalities threshold after - China, Italy, Iran and Spain. This tally only accounts for people who died in public hospitals, whereas several retirement homes have been reporting deaths in the double digits. Salomon said health authorities would soon be able to tabulate data coming from retirement homes, which will likely trigger a more dramatic increase in registered fatalities. He said the total number of infections in France had risen to 22,300, a 12% jump in 24 hours. Salomon added that 2,516 people were in a serious condition requiring life support, up by 21% from Monday, and that 8,000 hospital beds were now equipped with ventilators. Claim: French coronavirus death toll tops 1,000, lockdown likely to be extended.
Example Output: France became the fifth country to report more than 1,000 deaths from coronavirus on Tuesday and a government body dealing with the outbreak suggested the national lockdown imposed last week for an initial 15 days should last at least six weeks.

Example Input: Paragraph: Cost of treatment not mentioned. 5-year estimated outcomes were given after only 2 years of data. No quantitative data on safety presented. Absolute numbers provided. Limited long term data and small absolute benefit are key issues here. Does not mention the increase in cholesterol and cardiovascular disease among the women in the aromatase inhibitor group. Tamoxifen may have a positive, cholesterol-lowering effect, which is also not mentioned. Study design not adequately discussed. It didn’t really describe that some of the data were likely gathered on women with more advanced disease where the benefits would be bigger. Gives estimates of women diagnosed with this type of breast cancer. Perhaps not enough emphasis that this is only for post menopausal women with invasive disease — e.g. last line in story assumes all estrogen receptor/progesterone receptor positive women are eligible. Journalist notes that the study was funded by Novartis, maker of Femara, and that many of the researchers own stock in this company or in companies for rival drugs. Mentions other adjuvant drug treatment, tamoxifen, as well as some side effects of both of the aromatase inhibitor drugs (Femara and Arimide) studied as well as Tamoxifen. Story about FDA approval for women with early-stage invasive disease. Discusses how drug is already in use for women with advanced breast cancer. Claim: Drug OK’d to Fight Breast Cancer Relapse
Example Output:
This story summarized some of the findings from a recent New England Journal of Medicine article on the BIG I-98 Trial, which randomized approximately 8,000 women to either letrozole or tamoxifen for 5 years. The outcome of this study and similar large-scale, randomized double-blind trials have shown that aromatase inhibitors are effective in reducing rates of breast cancer recurrence in post-menopausal women with estrogen receptor positive tumors. However, there is not enough emphasis here that this is only for post menopausal women with invasive disease — e.g. last quote citing 800,000 women assumes all ER/PR positive women are eligible.The FDA has approved two aromatase inhibitors, Letrozole and Arimidex, for early-stage breast cancer. While this story provides a decent overview of how these medications work and the findings on which the new FDA approval is based, there is little information on some of the potentially serious side effects noted in the women who look letrozole. These side effects include an increase in cholesterol levels and cardiovascular disease, as well as a significant increase in the risk of bone fractures. There are no quantitative 5-year estimates of these side effects, nor is there a quantitative comparison with the Tamoxifen group, though the safety of each drug is briefly mentioned. Additionally, there is no mention of the cost of either drug. Since hormonal drug regimens (i.e. tamoxifen alone, aromatase inhibitors alone or aromatase inhibitors following a course of tamoxifen) might be prescribed for 5 years or more, a cost comparison would be important. Itâ€™s good that the story points out that the study is funded by pharmaceutical money and that some of the researchers own stock in Novartis. An independent source from the National Cancer Institute is quoted for balance, presumably with no ties to pharmaceutical funding.